Olive leaf extract Olea europaea L.
Also called: olive leaf, olive leaves, OLE, Oleae folium
Olive leaf products are made from the leaves of the olive tree, described in research as the richest source of olive phenolic compounds. They are used as teas, powdered leaf, and liquid or capsule extracts.
- Category
- Botanical
- Part used
- Leaf (fresh or dried leaf, powdered leaf, extracts)
- Strongest evidence
- C Limited
- Native range
- Native to Africa and the Mediterranean east to south-central China (POWO: "Africa, Medit. to SC. China")
- Reviewed
- 2026-10-29
Class 1 Well studied in people. A 2024 systematic review (Nutrition Reviews) included 12 RCTs (703 adults, 2 days to 12 weeks) of pure olive leaf extract taken by mouth versus placebo or a comparison group. [6]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CKidneys and bladder1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in prehypertensive men | C | Double-blind crossover RCT in 60 men: 6 weeks of extract (136 mg oleuropein daily) lowered daytime and 24-hour systolic and diastolic blood pressure versus control (24-h systolic -3.33 mmHg). [3] |
| Blood pressure in stage-1 hypertension (versus captopril) | C | In an 8-week double-blind trial, 500 mg extract twice daily lowered systolic pressure by 11.5 mmHg versus 13.7 mmHg with captopril; the difference between groups was not significant. [4] |
| Blood lipids and blood pressure in overweight adults | C | In an 8-week RCT of 77 overweight adults with mildly raised cholesterol, 500 mg/day extract did not change lipids, oxidized LDL, blood pressure, glucose or insulin versus placebo. [5] |
| Fasting blood glucose and cardiometabolic markers | C | A meta-analysis of 12 RCTs (703 adults, 2 days to 12 weeks) found that fasting glucose, in studies using low doses, favored the control group; authors called for more consistent trials. [6] |
| Mild water retention (EU traditional use) | C | The EU monograph accepts use to promote renal elimination of water in mild water retention, after serious conditions are excluded, exclusively on the basis of long-standing use. [7] |
Main constituents: Oleuropein, a major component of olive leaf [1]; Hydroxytyrosol; conjugated hydroxytyrosol metabolites are the main compounds found in blood and urine after olive leaf extract [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Studied in a trial: extract providing 136 mg oleuropein and 6 mg hydroxytyrosol daily for 6 weeks. [3]
- Studied in a trial: 500 mg extract twice daily for 8 weeks. [4]
- Studied in a trial: 500 mg extract daily for 8 weeks. [5]
- Stated in the EU traditional-use monograph (2017), adults: e.g. powdered dried leaves 630-1375 mg/day, or leaf infusions 6-30 g/day, traditionally for 2-4 weeks. [7]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingSafety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Antihypertensive drugs; Insulin and antidiabetic drugs
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
EU HMPC traditional use (31 January 2017), adults: decoction of 10 g fresh or 5 g dried leaves twice daily …
Details and sources
Interactions
| With | What happens |
|---|---|
| Blood pressure medicines | Olive leaf lowered blood pressure in rat models; clinical relevance has yet to be determined. [1] |
| Insulin and diabetes medicines | In vitro and animal models suggest blood-glucose-lowering effects; clinical relevance has yet to be determined. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- The EU monograph specifies leaf complying with the Ph. Eur. monograph for olive leaf (ref. 1878). [7]
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [8]
- EU: HMPC herbal monograph (2017) for traditional use to promote renal elimination of water in mild water retention. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming olive leaf (Olea europaea leaf) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. The list does include olive fruit extracts (NDI 396, 1293) and hydroxytyrosol (NDI 1163) without naming leaf as the source. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P7]
- Compliance with the Ph. Eur. monograph for olive leaf (1878) — Specified for the herbal substance in the EU HMPC monograph. [P6]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- In 9 adults given olive leaf extract (51.1 or 76.6 mg oleuropein), conjugated hydroxytyrosol metabolites were the main compounds in plasma and urine, all recovered in urine within 8 h, with wide inter-individual variation. [P1]
Formulations studied to change absorption
Human data only.
- Peak plasma oleuropein was higher after a liquid than a capsule extract (2.74 vs 0.47 ng/mL; p = 0.004), but peak conjugated hydroxytyrosol did not differ (p = 0.94); the liquid peaked earlier. [P1]
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU HMPC traditional use (31 January 2017), adults: decoction of 10 g fresh or 5 g dried leaves twice daily; infusion 6-10 g up to 3 times daily (6-30 g/day); powdered dried leaves 630-1375 mg/day; traditionally used for 2-4 weeks. [P6]
Pregnancy and breastfeeding
- Safety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended. [P6]
Sources for this profile
- de Bock M, et al. Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol Nutr Food Res 2013;57(11):2079-85 (PMID 23766098), 2013-11. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Olive Leaf (last updated April 12, 2023), 2023-04-12. mskcc.org
- EMA HMPC. European Union herbal monograph on Olea europaea L., folium, first version (EMA/HMPC/359238/2016, final, 31 January 2017), 2017-01-31. ema.europa.eu
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Olive Leaf (last updated April 12, 2023), 2023-04-12. mskcc.org
- de Bock M, et al. Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol Nutr Food Res 2013;57(11):2079-85 (PMID 23766098), 2013-11. pubmed.ncbi.nlm.nih.gov
- Lockyer S, et al. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial. Eur J Nutr 2017;56(4):1421-1432 (PMID 26951205), 2017-06. pubmed.ncbi.nlm.nih.gov
- Susalit E, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine 2011;18(4):251-8 (PMID 21036583), 2011-02-15. pubmed.ncbi.nlm.nih.gov
- Stevens Y, et al. The effect of olive leaf extract on cardiovascular health markers: a randomized placebo-controlled clinical trial. Eur J Nutr 2021;60(4):2111-2120 (PMID 33034707), 2021-06. pubmed.ncbi.nlm.nih.gov
- Álvares AA, et al. Olive leaf extract effect on cardiometabolic risk factors: a systematic review and meta-analysis of randomized clinical trials. Nutr Rev 2024;82(12):1710-1725 (PMID 38287654), 2024-12-01. pubmed.ncbi.nlm.nih.gov
- EMA HMPC. European Union herbal monograph on Olea europaea L., folium, first version (EMA/HMPC/359238/2016, final, 31 January 2017), 2017-01-31. ema.europa.eu
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Olea europaea L.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.